| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.43 | 0.01 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.16 | 0.3 |